As of early 2006, Andrew P. Rasdal held approximately 907,818 shares of DexCom's stock, translating to roughly 3.4% of the company. Throughout his tenure, his wealth was closely linked to this holding. His largest stake came when the stock was...

As of early 2006, Andrew P. Rasdal held approximately 907,818 shares of DexCom's stock, translating to roughly 3.4% of the company. Throughout his tenure, his wealth was closely linked to this holding. His largest stake came when the stock was trading at around $14.30, positioning him for substantial financial gains if the company's stock price appreciated. Despite fluctuations, Rasdal's position reflects a commitment to the company; as of 2007, his holdings represented a significant portion of his net wealth. However, he did not realize any major stock option gains during 2006 due to company performance. With no cash bonuses awarded, the pressure was on to meet revenue targets, which remained a focal point for investors and executives alike.